MRKR
MRKR
NASDAQ · Biotechnology

Marker Therapeutics Inc

$1.65
-0.01 (-0.60%)
As of Feb 8, 2:23 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.83M 3.86M 4.10M
Net Income -148,955 -155,305 -171,738
EPS
Profit Margin -3.9% -4.0% -4.2%
Rev Growth +3.3% +19.6% -4.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 11.42M 9.32M 9.35M
Total Equity 10.96M 11.45M 10.87M
D/E Ratio 1.04 0.81 0.86
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -206,512 -205,551 -243,961
Free Cash Flow -139,442 -168,121 -167,490